| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | poly(A) RNA polymerase activity | 1.38e-05 | 12 | 81 | 3 | GO:1990817 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | ERBB3 TENT4B LATS2 PAPOLA PIK3R3 STYK1 AAK1 SYK FGFR2 CDK11B ACVR1C PXK PAPOLG | 9.65e-05 | 938 | 81 | 13 | GO:0016772 |
| GeneOntologyMolecularFunction | neuregulin binding | 2.41e-04 | 6 | 81 | 2 | GO:0038132 | |
| GeneOntologyMolecularFunction | adenylyltransferase activity | 2.66e-04 | 31 | 81 | 3 | GO:0070566 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.62e-04 | 83 | 81 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 5.74e-04 | 9 | 81 | 2 | GO:0070016 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 5.78e-04 | 709 | 81 | 10 | GO:0016773 | |
| GeneOntologyMolecularFunction | protein kinase activity | 7.16e-04 | 600 | 81 | 9 | GO:0004672 | |
| GeneOntologyMolecularFunction | protein domain specific binding | STRN3 SCN2A STRN4 SYK OCLN ADGRL2 BHLHE40 NIPBL CRK DNMT1 SON | 7.89e-04 | 875 | 81 | 11 | GO:0019904 |
| GeneOntologyMolecularFunction | kinase activity | 1.02e-03 | 764 | 81 | 10 | GO:0016301 | |
| GeneOntologyMolecularFunction | phosphotyrosine residue binding | 1.16e-03 | 51 | 81 | 3 | GO:0001784 | |
| MousePheno | lethality throughout fetal growth and development | 3.89e-05 | 435 | 67 | 10 | MP:0006208 | |
| MousePheno | abnormal trophoblast layer morphology | 6.52e-05 | 211 | 67 | 7 | MP:0005031 | |
| MousePheno | abnormal naive B cell morphology | 6.77e-05 | 3 | 67 | 2 | MP:0008184 | |
| Domain | NTP_transf_2 | 1.22e-05 | 11 | 80 | 3 | PF01909 | |
| Domain | Polymerase_NTP_transf_dom | 1.22e-05 | 11 | 80 | 3 | IPR002934 | |
| Domain | TBP_CS | 1.81e-05 | 2 | 80 | 2 | IPR030491 | |
| Domain | TBP_eukaryotic | 1.81e-05 | 2 | 80 | 2 | IPR033710 | |
| Domain | Tyr_Pase_non-rcpt_typ-14/21 | 1.81e-05 | 2 | 80 | 2 | IPR014392 | |
| Domain | Striatin | 5.42e-05 | 3 | 80 | 2 | PF08232 | |
| Domain | - | 5.42e-05 | 3 | 80 | 2 | 3.30.70.590 | |
| Domain | TFIID | 5.42e-05 | 3 | 80 | 2 | PS00351 | |
| Domain | TBP | 5.42e-05 | 3 | 80 | 2 | PF00352 | |
| Domain | PAP_central | 5.42e-05 | 3 | 80 | 2 | PF04928 | |
| Domain | PAP_RNA-bind | 5.42e-05 | 3 | 80 | 2 | PF04926 | |
| Domain | PolA_pol_cen_dom | 5.42e-05 | 3 | 80 | 2 | IPR007012 | |
| Domain | PolA_pol_RNA-bd_dom | 5.42e-05 | 3 | 80 | 2 | IPR007010 | |
| Domain | TBP | 5.42e-05 | 3 | 80 | 2 | IPR000814 | |
| Domain | PolyA_polymerase | 5.42e-05 | 3 | 80 | 2 | IPR014492 | |
| Domain | Striatin_N | 5.42e-05 | 3 | 80 | 2 | IPR013258 | |
| Domain | NuclTrfase_I_C | 5.42e-05 | 3 | 80 | 2 | IPR011068 | |
| Domain | Pkinase_Tyr | 2.31e-04 | 129 | 80 | 5 | PF07714 | |
| Domain | Prot_kinase_dom | 2.40e-04 | 489 | 80 | 9 | IPR000719 | |
| Domain | PROTEIN_KINASE_DOM | 2.54e-04 | 493 | 80 | 9 | PS50011 | |
| Domain | Beta2_adaptin/TBP_C_dom | 2.69e-04 | 6 | 80 | 2 | IPR012295 | |
| Domain | - | 2.69e-04 | 6 | 80 | 2 | 3.30.310.10 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.16e-04 | 138 | 80 | 5 | IPR001245 | |
| Domain | zf-CW | 3.75e-04 | 7 | 80 | 2 | PF07496 | |
| Domain | Znf_CW | 3.75e-04 | 7 | 80 | 2 | IPR011124 | |
| Domain | ZF_CW | 3.75e-04 | 7 | 80 | 2 | PS51050 | |
| Domain | Kinase-like_dom | 5.08e-04 | 542 | 80 | 9 | IPR011009 | |
| Domain | PROTEIN_KINASE_ATP | 7.72e-04 | 459 | 80 | 8 | PS00107 | |
| Domain | PROTEIN_KINASE_TYR | 7.99e-04 | 97 | 80 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 7.99e-04 | 97 | 80 | 4 | IPR008266 | |
| Domain | HEAT | 1.97e-03 | 58 | 80 | 3 | IPR000357 | |
| Domain | - | 2.65e-03 | 222 | 80 | 5 | 1.25.10.10 | |
| Domain | FERM_CS | 4.70e-03 | 24 | 80 | 2 | IPR019747 | |
| Domain | FERM_C | 5.51e-03 | 26 | 80 | 2 | PF09380 | |
| Domain | G-protein_beta_WD-40_rep | 5.81e-03 | 85 | 80 | 3 | IPR020472 | |
| Domain | FERM_C | 5.93e-03 | 27 | 80 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 5.93e-03 | 27 | 80 | 2 | IPR018980 | |
| Domain | ARM-like | 6.06e-03 | 270 | 80 | 5 | IPR011989 | |
| Domain | TyrKc | 6.39e-03 | 88 | 80 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 6.39e-03 | 88 | 80 | 3 | IPR020635 | |
| Pubmed | 2.79e-06 | 371 | 82 | 8 | 25241761 | ||
| Pubmed | FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival. | 5.49e-06 | 2 | 82 | 2 | 18381441 | |
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 20705591 | ||
| Pubmed | 5.49e-06 | 2 | 82 | 2 | 18485118 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | JUP AMER1 PTPN14 CEP112 EXPH5 KIAA0232 SEC24B AAK1 PTPN21 VIRMA DNMT1 | 5.68e-06 | 861 | 82 | 11 | 36931259 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.04e-05 | 588 | 82 | 9 | 38580884 | |
| Pubmed | TBP/TFIID-dependent activation of MyoD target genes in skeletal muscle cells. | 1.64e-05 | 3 | 82 | 2 | 26880551 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 34459131 | ||
| Pubmed | Anaplasma phagocytophilum specifically induces tyrosine phosphorylation of ROCK1 during infection. | 1.64e-05 | 3 | 82 | 2 | 17346310 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 27151458 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 27340869 | ||
| Pubmed | SON is an essential RNA splicing factor promoting ErbB2 and ErbB3 expression in breast cancer. | 1.64e-05 | 3 | 82 | 2 | 39313574 | |
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 11940607 | ||
| Pubmed | 1.64e-05 | 3 | 82 | 2 | 33998651 | ||
| Pubmed | 2.47e-05 | 24 | 82 | 3 | 20624904 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 11136974 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 11042121 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 10748158 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 21624812 | ||
| Pubmed | The PSGL-1-L-selectin signaling complex regulates neutrophil adhesion under flow. | 3.28e-05 | 4 | 82 | 2 | 24127491 | |
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 31097223 | ||
| Pubmed | 3.28e-05 | 4 | 82 | 2 | 8491200 | ||
| Pubmed | 3.41e-05 | 77 | 82 | 4 | 22973453 | ||
| Pubmed | 3.82e-05 | 263 | 82 | 6 | 34702444 | ||
| Pubmed | STRN3 TENT4B CNOT6L SEC24B AAK1 STRN4 KDM1B ASCC3 VIRMA NIPBL MOV10 SON TBP | 4.63e-05 | 1497 | 82 | 13 | 31527615 | |
| Pubmed | 4.69e-05 | 549 | 82 | 8 | 38280479 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 18502210 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 27906180 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 17543554 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 16412700 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 12939402 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 12387735 | ||
| Pubmed | 5.47e-05 | 5 | 82 | 2 | 14697354 | ||
| Pubmed | 6.03e-05 | 418 | 82 | 7 | 34709266 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SETDB1 EYA4 AMER1 PTPN14 CNOT6L FAM210A SEC24B SEC23IP AAK1 CDH23 NCAPG2 MOV10 | 6.10e-05 | 1321 | 82 | 12 | 27173435 |
| Pubmed | SETDB1 PTPN14 PIK3R3 KDM1B CUL7 ASCC3 ADGRL2 TCF7L1 KNL1 SON TBP | 6.17e-05 | 1116 | 82 | 11 | 31753913 | |
| Pubmed | A quantitative protein interaction network for the ErbB receptors using protein microarrays. | 6.29e-05 | 90 | 82 | 4 | 16273093 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 6.93e-05 | 934 | 82 | 10 | 33916271 | |
| Pubmed | 7.84e-05 | 591 | 82 | 8 | 15231748 | ||
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 19307307 | ||
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 25352128 | ||
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 8647200 | ||
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 17641088 | ||
| Pubmed | Thrombspondin acts via integrin-associated protein to activate the platelet integrin alphaIIbbeta3. | 8.19e-05 | 6 | 82 | 2 | 9169439 | |
| Pubmed | 8.19e-05 | 6 | 82 | 2 | 20682778 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 8.80e-05 | 774 | 82 | 9 | 15302935 | |
| Pubmed | 9.69e-05 | 451 | 82 | 7 | 36168627 | ||
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 12808048 | ||
| Pubmed | 1.14e-04 | 7 | 82 | 2 | 31064775 | ||
| Pubmed | β-catenin and γ-catenin are dispensable for T lymphocytes and AML leukemic stem cells. | 1.14e-04 | 7 | 82 | 2 | 32820720 | |
| Pubmed | 1.17e-04 | 40 | 82 | 3 | 30898150 | ||
| Pubmed | SETDB1 JUP EYA4 IKZF3 SEC24B KLF3 KDM1B CUL7 MORC4 NIPBL MOV10 TBP | 1.28e-04 | 1429 | 82 | 12 | 35140242 | |
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 16289966 | ||
| Pubmed | Cell-junctional and cytoskeletal organization in mouse blastocysts lacking E-cadherin. | 1.52e-04 | 8 | 82 | 2 | 9187087 | |
| Pubmed | 1.52e-04 | 8 | 82 | 2 | 18794338 | ||
| Pubmed | 1.63e-04 | 216 | 82 | 5 | 31519766 | ||
| Pubmed | 1.68e-04 | 116 | 82 | 4 | 30804394 | ||
| Pubmed | RNA binding protein RBM46 regulates mitotic-to-meiotic transition in spermatogenesis. | 1.96e-04 | 9 | 82 | 2 | 36001654 | |
| Pubmed | beta-Catenin protects the epidermis from mechanical stresses. | 1.96e-04 | 9 | 82 | 2 | 23816618 | |
| Pubmed | ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling. | 1.96e-04 | 9 | 82 | 2 | 28086240 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 2.27e-04 | 232 | 82 | 5 | 25515538 | |
| Pubmed | JUP TCAF1 AMER1 CNOT6L PAPOLA FAM210A CEP112 ANKRD12 KDM1B EZHIP | 2.33e-04 | 1084 | 82 | 10 | 11544199 | |
| Pubmed | 2.44e-04 | 10 | 82 | 2 | 14517306 | ||
| Pubmed | 2.69e-04 | 708 | 82 | 8 | 39231216 | ||
| Pubmed | 2.69e-04 | 533 | 82 | 7 | 25544563 | ||
| Pubmed | 2.92e-04 | 134 | 82 | 4 | 24658140 | ||
| Pubmed | A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype. | 2.98e-04 | 11 | 82 | 2 | 24623306 | |
| Pubmed | The murine gene, Traube, is essential for the growth of preimplantation embryos. | 2.98e-04 | 11 | 82 | 2 | 11071758 | |
| Pubmed | 3.03e-04 | 55 | 82 | 3 | 27114453 | ||
| Pubmed | 3.39e-04 | 733 | 82 | 8 | 34672954 | ||
| Pubmed | 3.57e-04 | 12 | 82 | 2 | 30237243 | ||
| Pubmed | 3.57e-04 | 12 | 82 | 2 | 21951552 | ||
| Pubmed | 3.57e-04 | 12 | 82 | 2 | 21402781 | ||
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 3.67e-04 | 742 | 82 | 8 | 26871637 | |
| Pubmed | 3.69e-04 | 399 | 82 | 6 | 37536630 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 3.78e-04 | 942 | 82 | 9 | 31073040 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 3.82e-04 | 565 | 82 | 7 | 25468996 | |
| Pubmed | MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway. | 4.21e-04 | 13 | 82 | 2 | 33571521 | |
| Pubmed | Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. | 4.21e-04 | 13 | 82 | 2 | 17827388 | |
| Pubmed | 4.21e-04 | 13 | 82 | 2 | 23277359 | ||
| Pubmed | Gene array identification of Ipf1/Pdx1-/- regulated genes in pancreatic progenitor cells. | 4.21e-04 | 13 | 82 | 2 | 18036209 | |
| Pubmed | 4.21e-04 | 13 | 82 | 2 | 15907834 | ||
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 4.21e-04 | 13 | 82 | 2 | 22085899 | |
| Pubmed | JAGGED1/NOTCH3 activation promotes aortic hypermuscularization and stenosis in elastin deficiency. | 4.21e-04 | 13 | 82 | 2 | 34990407 | |
| Pubmed | USP9X Deubiquitylates DVL2 to Regulate WNT Pathway Specification. | 4.32e-04 | 62 | 82 | 3 | 31340145 | |
| Pubmed | Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. | 4.37e-04 | 149 | 82 | 4 | 25231870 | |
| Pubmed | 4.43e-04 | 963 | 82 | 9 | 28671696 | ||
| Pubmed | 4.90e-04 | 421 | 82 | 6 | 36976175 | ||
| Pubmed | FoxO6 regulates Hippo signaling and growth of the craniofacial complex. | 4.91e-04 | 14 | 82 | 2 | 30286078 | |
| Pubmed | ERBB3-mediated regulation of Bergmann glia proliferation in cerebellar lamination. | 4.91e-04 | 14 | 82 | 2 | 25564653 | |
| Pubmed | Deterministic and stochastic allele specific gene expression in single mouse blastomeres. | 5.08e-04 | 424 | 82 | 6 | 21731673 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | 6.02e-04 | 1005 | 82 | 9 | 19615732 | |
| Pubmed | 6.17e-04 | 70 | 82 | 3 | 34255829 | ||
| Pubmed | 6.45e-04 | 16 | 82 | 2 | 19464057 | ||
| Pubmed | 6.45e-04 | 16 | 82 | 2 | 11564885 | ||
| Pubmed | 6.62e-04 | 446 | 82 | 6 | 24255178 | ||
| Pubmed | 6.98e-04 | 73 | 82 | 3 | 24728074 | ||
| Pubmed | Association analyses identify three susceptibility Loci for vitiligo in the Chinese Han population. | 7.30e-04 | 17 | 82 | 2 | 22951725 | |
| Pubmed | 7.30e-04 | 17 | 82 | 2 | 29299163 | ||
| Pubmed | Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. | 7.30e-04 | 17 | 82 | 2 | 17510365 | |
| Interaction | PIK3R1 interactions | SELPLG DPP4 JUP ERBB3 IKZF3 PIK3R3 STYK1 SYK FGFR2 OCLN VIRMA PXK CRK | 1.12e-08 | 412 | 82 | 13 | int:PIK3R1 |
| Interaction | PIK3R2 interactions | 3.22e-08 | 230 | 82 | 10 | int:PIK3R2 | |
| Interaction | SEC24B interactions | 5.71e-07 | 240 | 82 | 9 | int:SEC24B | |
| Interaction | SH2D2A interactions | 2.20e-06 | 52 | 82 | 5 | int:SH2D2A | |
| Interaction | APC interactions | 3.97e-06 | 389 | 82 | 10 | int:APC | |
| Interaction | ZFYVE9 interactions | 4.65e-06 | 106 | 82 | 6 | int:ZFYVE9 | |
| Interaction | WWC2 interactions | 4.84e-06 | 28 | 82 | 4 | int:WWC2 | |
| Interaction | GAB1 interactions | 8.11e-06 | 178 | 82 | 7 | int:GAB1 | |
| Interaction | YWHAG interactions | JUP AMER1 PTPN14 LATS2 FOXO6 CEP112 EXPH5 KIAA0232 SEC24B AAK1 CDK11B PTPN21 CUL7 VIRMA CRK DNMT1 SON | 9.07e-06 | 1248 | 82 | 17 | int:YWHAG |
| Interaction | PTK2B interactions | 9.07e-06 | 119 | 82 | 6 | int:PTK2B | |
| Interaction | CEP295 interactions | 1.04e-05 | 71 | 82 | 5 | int:CEP295 | |
| Interaction | ITGA5 interactions | 1.32e-05 | 127 | 82 | 6 | int:ITGA5 | |
| Interaction | SOBP interactions | 1.39e-05 | 12 | 82 | 3 | int:SOBP | |
| Interaction | VBP1 interactions | 1.90e-05 | 203 | 82 | 7 | int:VBP1 | |
| Interaction | MET interactions | 2.37e-05 | 290 | 82 | 8 | int:MET | |
| Interaction | ERBB2 interactions | JUP ERBB3 LATS2 PIK3R3 SEC24B STYK1 SYK FGFR2 OCLN VIRMA CRK | 2.59e-05 | 589 | 82 | 11 | int:ERBB2 |
| Interaction | STXBP4 interactions | 2.65e-05 | 86 | 82 | 5 | int:STXBP4 | |
| Interaction | RALGAPA1 interactions | 2.80e-05 | 87 | 82 | 5 | int:RALGAPA1 | |
| Interaction | TAF3 interactions | 2.96e-05 | 88 | 82 | 5 | int:TAF3 | |
| Interaction | HDAC1 interactions | SETDB1 JUP IKZF3 LATS2 PAPOLA SEC23IP SYK ASCC3 MORC4 BHLHE40 VIRMA CRK DNMT1 KNL1 TBP | 3.57e-05 | 1108 | 82 | 15 | int:HDAC1 |
| Interaction | CRKL interactions | 3.89e-05 | 227 | 82 | 7 | int:CRKL | |
| Interaction | WWC1 interactions | 4.07e-05 | 94 | 82 | 5 | int:WWC1 | |
| Interaction | FER interactions | 5.08e-05 | 50 | 82 | 4 | int:FER | |
| Interaction | QSER1 interactions | 5.48e-05 | 100 | 82 | 5 | int:QSER1 | |
| Interaction | MAP4K5 interactions | 6.03e-05 | 102 | 82 | 5 | int:MAP4K5 | |
| Interaction | NFYA interactions | 6.92e-05 | 105 | 82 | 5 | int:NFYA | |
| Interaction | MAP4K4 interactions | 7.91e-05 | 254 | 82 | 7 | int:MAP4K4 | |
| Interaction | RFX7 interactions | 8.19e-05 | 21 | 82 | 3 | int:RFX7 | |
| Interaction | FIRRE interactions | 9.76e-05 | 4 | 82 | 2 | int:FIRRE | |
| Interaction | MIF4GD-DT interactions | 9.76e-05 | 4 | 82 | 2 | int:MIF4GD-DT | |
| Interaction | SNORA8 interactions | 9.76e-05 | 4 | 82 | 2 | int:SNORA8 | |
| Interaction | DOK1 interactions | 9.77e-05 | 59 | 82 | 4 | int:DOK1 | |
| Interaction | PPIP5K2 interactions | 1.26e-04 | 63 | 82 | 4 | int:PPIP5K2 | |
| Interaction | YWHAH interactions | JUP AMER1 PTPN14 LATS2 FOXO6 CEP112 EXPH5 KIAA0232 SEC24B AAK1 PTPN21 VIRMA CRK DNMT1 | 1.32e-04 | 1102 | 82 | 14 | int:YWHAH |
| Interaction | CEP192 interactions | 1.33e-04 | 192 | 82 | 6 | int:CEP192 | |
| Interaction | HSH2D interactions | 1.40e-04 | 25 | 82 | 3 | int:HSH2D | |
| Interaction | YES1 interactions | 1.43e-04 | 375 | 82 | 8 | int:YES1 | |
| Interaction | EPHA2 interactions | JUP PTPN14 LATS2 PIK3R3 SEC24B SEC23IP STYK1 FGFR2 OCLN ADGRL2 ITGB3 | 1.54e-04 | 719 | 82 | 11 | int:EPHA2 |
| Interaction | LYN interactions | DPP4 JUP ERBB3 PTPN14 PIK3R3 SYK CDH23 FGFR2 OCLN ADGRL2 VIRMA | 1.56e-04 | 720 | 82 | 11 | int:LYN |
| Interaction | KIT interactions | 1.58e-04 | 125 | 82 | 5 | int:KIT | |
| Interaction | GHRH interactions | 1.62e-04 | 5 | 82 | 2 | int:GHRH | |
| Interaction | DDX11 interactions | 1.70e-04 | 68 | 82 | 4 | int:DDX11 | |
| Interaction | PDGFRA interactions | 1.71e-04 | 385 | 82 | 8 | int:PDGFRA | |
| Interaction | MAP4K1 interactions | 1.90e-04 | 130 | 82 | 5 | int:MAP4K1 | |
| Interaction | TCF3 interactions | 2.00e-04 | 295 | 82 | 7 | int:TCF3 | |
| Interaction | YWHAB interactions | PTPN14 FOXO6 CEP112 EXPH5 KIAA0232 AAK1 FGFR2 CDK11B PTPN21 CUL7 VIRMA CRK SON | 2.17e-04 | 1014 | 82 | 13 | int:YWHAB |
| Interaction | SCARNA5 interactions | 2.43e-04 | 6 | 82 | 2 | int:SCARNA5 | |
| Interaction | FOXO3B interactions | 2.43e-04 | 6 | 82 | 2 | int:FOXO3B | |
| Interaction | YWHAZ interactions | JUP ERBB3 PTPN14 LATS2 CEP112 EXPH5 KIAA0232 AAK1 CDK11B PTPN21 CUL7 VIRMA CRK MOV10 DNMT1 | 2.50e-04 | 1319 | 82 | 15 | int:YWHAZ |
| Interaction | GPS2 interactions | 3.05e-04 | 144 | 82 | 5 | int:GPS2 | |
| Interaction | FBXO38 interactions | 3.15e-04 | 145 | 82 | 5 | int:FBXO38 | |
| Interaction | CCDC88A interactions | 3.20e-04 | 226 | 82 | 6 | int:CCDC88A | |
| Interaction | URGCP interactions | 3.24e-04 | 33 | 82 | 3 | int:URGCP | |
| Interaction | NEDD4L interactions | 3.27e-04 | 320 | 82 | 7 | int:NEDD4L | |
| Interaction | MAGI1 interactions | 3.35e-04 | 147 | 82 | 5 | int:MAGI1 | |
| Interaction | JPH1 interactions | 3.36e-04 | 228 | 82 | 6 | int:JPH1 | |
| Interaction | NRG2 interactions | 3.39e-04 | 7 | 82 | 2 | int:NRG2 | |
| Interaction | H4C5 interactions | 3.55e-04 | 34 | 82 | 3 | int:H4C5 | |
| Interaction | SRC interactions | 3.56e-04 | 664 | 82 | 10 | int:SRC | |
| Interaction | ZNF263 interactions | 3.57e-04 | 149 | 82 | 5 | int:ZNF263 | |
| Interaction | UBXN6 interactions | 3.59e-04 | 325 | 82 | 7 | int:UBXN6 | |
| Interaction | NOLC1 interactions | 3.59e-04 | 325 | 82 | 7 | int:NOLC1 | |
| Interaction | GOLGA3 interactions | 3.60e-04 | 231 | 82 | 6 | int:GOLGA3 | |
| Interaction | PLEC interactions | 3.61e-04 | 430 | 82 | 8 | int:PLEC | |
| Interaction | FYN interactions | 3.67e-04 | 431 | 82 | 8 | int:FYN | |
| Interaction | MAP3K3 interactions | 3.84e-04 | 84 | 82 | 4 | int:MAP3K3 | |
| Interaction | NEDD9 interactions | 4.01e-04 | 85 | 82 | 4 | int:NEDD9 | |
| Interaction | KDM1A interactions | SETDB1 JUP IKZF3 SEC23IP KLF3 KDM1B ASCC3 MORC4 VIRMA CRK DNMT1 KNL1 | 4.07e-04 | 941 | 82 | 12 | int:KDM1A |
| Interaction | ADGRL2 interactions | 4.20e-04 | 86 | 82 | 4 | int:ADGRL2 | |
| Interaction | URM1 interactions | 4.21e-04 | 36 | 82 | 3 | int:URM1 | |
| Interaction | YPEL1 interactions | 4.51e-04 | 8 | 82 | 2 | int:YPEL1 | |
| Interaction | ORAI2 interactions | 4.51e-04 | 8 | 82 | 2 | int:ORAI2 | |
| Interaction | SNAI3 interactions | 4.51e-04 | 8 | 82 | 2 | int:SNAI3 | |
| Interaction | LRRC37B interactions | 4.51e-04 | 8 | 82 | 2 | int:LRRC37B | |
| Interaction | SNHG1 interactions | 4.51e-04 | 8 | 82 | 2 | int:SNHG1 | |
| Interaction | STAT3 interactions | 4.60e-04 | 446 | 82 | 8 | int:STAT3 | |
| Interaction | TRIP11 interactions | 4.67e-04 | 158 | 82 | 5 | int:TRIP11 | |
| Interaction | NBEA interactions | 4.78e-04 | 89 | 82 | 4 | int:NBEA | |
| Interaction | MAN1A1 interactions | 4.78e-04 | 89 | 82 | 4 | int:MAN1A1 | |
| Interaction | PKP4 interactions | 4.80e-04 | 159 | 82 | 5 | int:PKP4 | |
| Interaction | NCK1 interactions | 4.81e-04 | 244 | 82 | 6 | int:NCK1 | |
| Interaction | PLA2G2A interactions | 4.94e-04 | 38 | 82 | 3 | int:PLA2G2A | |
| Interaction | YWHAE interactions | JUP PTPN14 PAPOLA CEP112 EXPH5 KIAA0232 SEC23IP AAK1 CDK11B PTPN21 CUL7 VIRMA CRK DNMT1 | 5.05e-04 | 1256 | 82 | 14 | int:YWHAE |
| Interaction | STYK1 interactions | 5.08e-04 | 161 | 82 | 5 | int:STYK1 | |
| Interaction | PPP1CA interactions | 5.14e-04 | 696 | 82 | 10 | int:PPP1CA | |
| Interaction | RAPGEF1 interactions | 5.34e-04 | 39 | 82 | 3 | int:RAPGEF1 | |
| Interaction | ZNF772 interactions | 5.78e-04 | 9 | 82 | 2 | int:ZNF772 | |
| Interaction | INSR interactions | 5.88e-04 | 353 | 82 | 7 | int:INSR | |
| Interaction | GARRE1 interactions | 6.00e-04 | 167 | 82 | 5 | int:GARRE1 | |
| Interaction | CPSF1 interactions | 6.07e-04 | 255 | 82 | 6 | int:CPSF1 | |
| Interaction | ERBB3 interactions | 6.08e-04 | 355 | 82 | 7 | int:ERBB3 | |
| Interaction | AMOTL1 interactions | 6.12e-04 | 95 | 82 | 4 | int:AMOTL1 | |
| Interaction | MAGEA1 interactions | 6.12e-04 | 95 | 82 | 4 | int:MAGEA1 | |
| Interaction | DSG2 interactions | 6.19e-04 | 256 | 82 | 6 | int:DSG2 | |
| Interaction | CEP85 interactions | 6.33e-04 | 169 | 82 | 5 | int:CEP85 | |
| Interaction | TRIP6 interactions | 6.39e-04 | 358 | 82 | 7 | int:TRIP6 | |
| Interaction | AR interactions | JUP LATS2 EXPH5 PIK3R3 SYK MORC4 VIRMA NIPBL CRK KNL1 SON TBP | 6.51e-04 | 992 | 82 | 12 | int:AR |
| Interaction | APRT interactions | 6.62e-04 | 97 | 82 | 4 | int:APRT | |
| Interaction | DSN1 interactions | 6.62e-04 | 97 | 82 | 4 | int:DSN1 | |
| Interaction | STRIP1 interactions | 6.62e-04 | 97 | 82 | 4 | int:STRIP1 | |
| GeneFamily | Zinc fingers CW-type | 1.89e-04 | 7 | 55 | 2 | 96 | |
| GeneFamily | WD repeat domain containing|Protein phosphatase 2 regulatory subunits | 9.30e-04 | 15 | 55 | 2 | 696 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 1.35e-03 | 18 | 55 | 2 | 812 | |
| GeneFamily | Protein phosphatase catalytic subunits|STRIPAK complex | 1.67e-03 | 20 | 55 | 2 | 1371 | |
| GeneFamily | SH2 domain containing | 3.60e-03 | 101 | 55 | 3 | 741 | |
| Coexpression | HALLMARK_UV_RESPONSE_DN | 6.15e-06 | 144 | 82 | 6 | M5942 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 3.74e-05 | 198 | 82 | 6 | M9119 | |
| Coexpression | GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP | 3.96e-05 | 200 | 82 | 6 | M9175 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 3.96e-05 | 200 | 82 | 6 | M6102 | |
| Coexpression | DURAND_STROMA_S_UP | 4.38e-05 | 300 | 82 | 7 | M2581 | |
| Coexpression | DURAND_STROMA_S_UP | 4.76e-05 | 304 | 82 | 7 | MM1083 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.36e-06 | 189 | 82 | 6 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | COVID-19_Mild-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 6.11e-06 | 140 | 82 | 5 | b1429028c52f84127b894b93b55961badcd5246f | |
| ToppCell | Control-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.01e-06 | 148 | 82 | 5 | 662c057030effc9eb61216e81d3967e6983c244f | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-dnT|Leuk-UTI / Disease, Lineage and Cell Type | 8.27e-06 | 149 | 82 | 5 | 53f145cf7089d948d41aa3c443e983e011826836 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-06 | 150 | 82 | 5 | 973252f4de9a1194aea9f3cb0e1f113643f16c91 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-05 | 172 | 82 | 5 | eba1568d4307e91c94fc616549057cbed8df5840 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-05 | 177 | 82 | 5 | f35b04c3557ebbdeba37dec54c8f45880eafb422 | |
| ToppCell | Control-Epithelial-Basal|World / Disease state, Lineage and Cell class | 2.17e-05 | 182 | 82 | 5 | 759390dde9b18757f7675d13d44c89d0e32f8d93 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 182 | 82 | 5 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 182 | 82 | 5 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 182 | 82 | 5 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 2.17e-05 | 182 | 82 | 5 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.41e-05 | 186 | 82 | 5 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | E12.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.48e-05 | 187 | 82 | 5 | baff4edc1bf64e3e03864a434fa47075ff7372fd | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.48e-05 | 187 | 82 | 5 | 6981b856187a2e689260ecb7d0a1193a374ee9b9 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.54e-05 | 188 | 82 | 5 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.54e-05 | 188 | 82 | 5 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-05 | 189 | 82 | 5 | a9864873b19ab3e60acf11f288fa7275badc2e42 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.67e-05 | 190 | 82 | 5 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-05 | 190 | 82 | 5 | b3bccf4dd95e986db3cee324a6737f5fcc22e8e5 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 2.74e-05 | 191 | 82 | 5 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 2.81e-05 | 192 | 82 | 5 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.88e-05 | 193 | 82 | 5 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.88e-05 | 193 | 82 | 5 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 194 | 82 | 5 | 11709704079f24a730476572dc2f01e9d2226e2c | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 194 | 82 | 5 | 3a1f95639d5f239f001bd67d4213e8938e7f299d | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4|GI_small-bowel / Manually curated celltypes from each tissue | 2.95e-05 | 194 | 82 | 5 | 4547b57669be5d4f0de55175802ee04372288a6a | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.02e-05 | 195 | 82 | 5 | 0a72b8446399807ace5b6c72f865bb40dbd9e92d | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-aorta_endothelial_cell|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 195 | 82 | 5 | 3969b8d5fcec8ef1831531a781f7bbcebab5a4ba | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.10e-05 | 196 | 82 | 5 | 7b17d47b7758d8ccf9dbefd097aeb553791a1eed | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.25e-05 | 198 | 82 | 5 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 3.33e-05 | 199 | 82 | 5 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Biopsy_Other_PF-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.33e-05 | 199 | 82 | 5 | 036244251d2dd39f8184b7095418c723c0524eff | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.41e-05 | 200 | 82 | 5 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.41e-05 | 200 | 82 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 142 | 82 | 4 | c2a3cd9998fd9a8e6b2665347ca5c32511776488 | |
| ToppCell | pdx-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.45e-04 | 144 | 82 | 4 | 0b94d978262a826c9254145aa98c6c30240243f9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 146 | 82 | 4 | e887e9de895fd453faa703997ef372cc6410fc49 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-04 | 148 | 82 | 4 | 18cfecd6ae20edb74f5d44ba759909df356acf3a | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-04 | 150 | 82 | 4 | 207fc230d7721149c7afc7970dd56817f52801d8 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(Cd4+_Tnaive-Tcm)|Lymphoid / shred on cell class and cell subclass (v4) | 1.83e-04 | 153 | 82 | 4 | ffb8ac88513e83d3ba01574e60beb5476154372b | |
| ToppCell | facs-MAT-Fat-3m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 154 | 82 | 4 | 391d40ef902773ffe832a50a14d35d31c56d3723 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.97e-04 | 156 | 82 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.07e-04 | 158 | 82 | 4 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 158 | 82 | 4 | debebc8534a80e5500051f6fd352dc201585968d | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Pld5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.12e-04 | 159 | 82 | 4 | a082e770fa757c4a1d3ed13d53f83297e36faf05 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 159 | 82 | 4 | 51bdbacb79227fbee38bb8680c58cb99878df0c7 | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-04 | 159 | 82 | 4 | 796e63f6052189106359a4e01eae3e466bf1d593 | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 2.12e-04 | 159 | 82 | 4 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_TEM|URO / Disease, Lineage and Cell Type | 2.17e-04 | 160 | 82 | 4 | e406f77b1c1a01d74f39ba65f99d5f8c7d75faf1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 160 | 82 | 4 | 94e4f5fc2156dd8163811c3b8b0781ea9b3f2e06 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.28e-04 | 162 | 82 | 4 | af9999e5fcd28ff1f401d52fd220315752c40027 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.28e-04 | 162 | 82 | 4 | 25bb1b9709f960fdf90faff56e874f52a8f5d17e | |
| ToppCell | facs-Marrow-Granulocytes-18m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-04 | 163 | 82 | 4 | 7a04192710f55acf5a4681d5f09942358fdb02ff | |
| ToppCell | facs-BAT-Fat-18m-Lymphocytic-NK_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 164 | 82 | 4 | ab9c17f86b98e1a4d5db1bd3086edab1320ebda8 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Natural_Killer|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 164 | 82 | 4 | e9e5a1462d8ed60b2e5bf603c8c47eb85bce83d5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-04 | 165 | 82 | 4 | 9bd332e5ede759a00a47728ea5558c215efdd77a | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 166 | 82 | 4 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 166 | 82 | 4 | 8e5a262dc4f04c5fc75b9a7a907832a0d7877df0 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-NK_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 166 | 82 | 4 | 0b7503e27e26dcbf7f1b893c32ce0b21ce58bd4a | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-granulocyte-monocyte_progenitor|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 166 | 82 | 4 | e01c720de6d4ca144c55378e023e718a64bf32f6 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.50e-04 | 166 | 82 | 4 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-04 | 166 | 82 | 4 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.67e-04 | 169 | 82 | 4 | 5f522a10b6ec24a353f53bec2f779a81cd5f9581 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.74e-04 | 170 | 82 | 4 | fefb07a7e308b620f946b9ff2b01e1796446fe38 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.80e-04 | 171 | 82 | 4 | 0eea035fde32cc2a75a0d4227911edb5d54ed47e | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.99e-04 | 174 | 82 | 4 | 1d157f7a919c8246e83d8060d2a0017c6c781ef3 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 175 | 82 | 4 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-04 | 175 | 82 | 4 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.19e-04 | 177 | 82 | 4 | 4672cc75225a4a23b298afa8ce439628262519db | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.19e-04 | 177 | 82 | 4 | 84591e28482ab62a5ef41e61043eb64912766356 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.19e-04 | 177 | 82 | 4 | 4bc100062891d07cacd10ffba38966cc6302c92f | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.19e-04 | 177 | 82 | 4 | 9f3a2adb9cd4f0a059afc87b6e377a9702154bb1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.19e-04 | 177 | 82 | 4 | 75cb2067a3f2d1b5a964890b02b604d1e79bd163 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.33e-04 | 179 | 82 | 4 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.33e-04 | 179 | 82 | 4 | 5aa8465e943b6b666c7f8b1937fcc3764bfe91f6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-04 | 179 | 82 | 4 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 3.40e-04 | 180 | 82 | 4 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-04 | 181 | 82 | 4 | fcc94f04dae98b817ec06b282d2e887804d37ae5 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.47e-04 | 181 | 82 | 4 | c783c2ecca7ab8e07646fa92dc7d436d24939d03 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.47e-04 | 181 | 82 | 4 | b7c85fbef3c06d5dc32a2a58f8d3dfabf1d79d9f | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-Basal_IFE|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-04 | 182 | 82 | 4 | 22d6f4790950508e8aa27e02a8133af5f53f13c8 | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 3.54e-04 | 182 | 82 | 4 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.54e-04 | 182 | 82 | 4 | 204530444e35d4977a7239ac176f477e9e5c29ab | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.62e-04 | 183 | 82 | 4 | 4c566be2dbbac36936f065af57b524403aae9711 | |
| ToppCell | Mild/Remission-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.69e-04 | 184 | 82 | 4 | 3d4864605c812862cf8926e02370eea3b8ccf32f | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.77e-04 | 185 | 82 | 4 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-Th1|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.77e-04 | 185 | 82 | 4 | 326c8b6ea0e9140616d7b867db1385b980dc3678 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.77e-04 | 185 | 82 | 4 | 3d73b3e0bceb192257e5cfbe64b7ccb379b6e22d | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.85e-04 | 186 | 82 | 4 | fc0b488c201a32d829047b58460297df2818b45d | |
| ToppCell | NS-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.85e-04 | 186 | 82 | 4 | c28f62524637c7eb9c43c9ec38fb12dfec6f5566 | |
| ToppCell | facs-Heart-LA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-04 | 186 | 82 | 4 | 246503fd4e6ae24041c606b069eb5fb313e60f73 | |
| ToppCell | facs-Heart-LA-24m-Myeloid-macrophage|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-04 | 186 | 82 | 4 | ef93ac469eb4f63db036f14b442c1503b8c6de38 | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 3.85e-04 | 186 | 82 | 4 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 3.85e-04 | 186 | 82 | 4 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-04 | 187 | 82 | 4 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Endothelial-endothelial_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-04 | 187 | 82 | 4 | 3548a9914c2b2f5d805798ce22ab26eab6d03897 | |
| ToppCell | E12.5-Epithelial|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.92e-04 | 187 | 82 | 4 | 29ea5e14dac3321df76f6aa4f053068b49c4a4bf | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-04 | 187 | 82 | 4 | 9aa411ae9b5a923378a5daebb8bb2fc2613f2510 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.92e-04 | 187 | 82 | 4 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| Computational | Genes in the cancer module 180. | 1.79e-04 | 119 | 48 | 5 | MODULE_180 | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HG-U133A | 7.66e-06 | 199 | 82 | 7 | 1960_DN | |
| Drug | acetonate | 1.25e-05 | 13 | 82 | 3 | CID000011671 | |
| Drug | 1,1,3-tribromopropane | 1.28e-05 | 2 | 82 | 2 | CID000134838 | |
| Drug | beta-naphthyl triphosphate | 1.28e-05 | 2 | 82 | 2 | CID000193862 | |
| Disease | prostate cancer (is_marker_for) | 6.76e-05 | 156 | 80 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Malignant neoplasm of breast | ERBB3 PTPN14 SYT3 FAM210A GPX2 COLGALT2 FGFR2 OCLN NIPBL TCF7L1 DNMT1 | 1.49e-04 | 1074 | 80 | 11 | C0006142 |
| Disease | permanent dental caries | 1.51e-04 | 7 | 80 | 2 | EFO_0600096 | |
| Disease | Head and Neck Carcinoma | 3.22e-04 | 10 | 80 | 2 | C3887461 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 3.96e-04 | 228 | 80 | 5 | EFO_0003948, MONDO_0004975 | |
| Disease | carcinoma (implicated_via_orthology) | 7.10e-04 | 64 | 80 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | brain connectivity measurement | 7.72e-04 | 400 | 80 | 6 | EFO_0005210 | |
| Disease | hearing loss | 8.11e-04 | 67 | 80 | 3 | EFO_0004238 | |
| Disease | Benign neoplasm of stomach | 9.61e-04 | 17 | 80 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 9.61e-04 | 17 | 80 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 9.61e-04 | 17 | 80 | 2 | C0154060 | |
| Disease | dyslexia | 1.00e-03 | 162 | 80 | 4 | EFO_0005424 | |
| Disease | age at menarche | 1.16e-03 | 594 | 80 | 7 | EFO_0004703 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 1.17e-03 | 169 | 80 | 4 | DOID:3908 (is_marker_for) | |
| Disease | total blood protein measurement | 1.40e-03 | 449 | 80 | 6 | EFO_0004536 | |
| Disease | Stomach Carcinoma | 1.47e-03 | 21 | 80 | 2 | C0699791 | |
| Disease | endometriosis (is_marker_for) | 2.09e-03 | 25 | 80 | 2 | DOID:289 (is_marker_for) | |
| Disease | lymphocyte percentage of leukocytes | 2.19e-03 | 665 | 80 | 7 | EFO_0007993 | |
| Disease | systemic scleroderma, systemic lupus erythematosus | 2.26e-03 | 26 | 80 | 2 | EFO_0000717, MONDO_0007915 | |
| Disease | testosterone measurement | AMER1 ST3GAL5 CEP112 UGT1A6 SEC23IP PTPN21 ADGRL2 ZNF654 NR1H4 KNL1 | 2.31e-03 | 1275 | 80 | 10 | EFO_0004908 |
| Disease | hearing impairment | 2.43e-03 | 98 | 80 | 3 | C1384666 | |
| Disease | Schizophrenia | 2.70e-03 | 883 | 80 | 8 | C0036341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEMYPVPPITRALLY | 86 | A0A1B0GUX0 | |
| YMSTPPPVKEYLQDR | 221 | Q96ND0 | |
| PPRPSSLEELGYEYM | 1211 | P21860 | |
| YILMDPSPEYAPIFG | 486 | P26358 | |
| RYMLEPDPDKRPDIY | 291 | Q2M2I8 | |
| YLIPPSATAYLPMLE | 326 | O14503 | |
| LPYYDMVPSDPSIEE | 416 | Q8NER5 | |
| PSYMSIYFDEPNPAR | 96 | Q8N8E3 | |
| ASRVPLLDYGYPLMP | 46 | Q3C1V8 | |
| LYTSMPNLRDSPYPE | 1371 | O95490 | |
| YMLLDPVRSYPGLAP | 436 | Q5JTC6 | |
| SEPAVPDLFPLYLEM | 176 | Q8TC27 | |
| EYFRETPLPIDPSMF | 721 | P21127 | |
| TTPRPPVEYDSDFML | 1221 | Q6UB98 | |
| APYYINLVEMTPPDS | 781 | Q9H251 | |
| LPEPPALSVMYSYLH | 181 | Q6NXP0 | |
| MIPVPYVEKYRPASA | 181 | P46108 | |
| RPMLSQPAYSFYPED | 36 | Q16625 | |
| PPSDYVERVDSPMAY | 311 | Q16625 | |
| YSPGIYELRRMPAET | 91 | Q96RI1 | |
| DGYRPSMLYIEDPLQ | 351 | Q8NDF8 | |
| PPGMEYSYDINRVPE | 581 | P21802 | |
| PYFAMPVREPERYPL | 136 | A6NJV1 | |
| PGIEPQRTDYYPEEM | 201 | P57682 | |
| PYIEMDSPILGDYRA | 106 | O95751 | |
| PTALEEMPRPYVDYL | 201 | Q9NRM7 | |
| LPMDTEVYESPYADP | 341 | P43405 | |
| PYMPYLESRDRGLSS | 2341 | O43451 | |
| PESLRYALMPEFYAL | 466 | Q86X51 | |
| YALMPEFYALSPVPP | 471 | Q86X51 | |
| YMSITSFPRLPEDEP | 21 | Q9UJ14 | |
| VEMYYEAFPPLSEKP | 171 | Q92628 | |
| PMTELYAVPYVLPED | 466 | Q14999 | |
| EALEALAPSSPLMYP | 266 | A8MYZ6 | |
| MEDYSPPPSLSEVAR | 1156 | Q6KC79 | |
| APSPMEIDPADKYVY | 391 | Q8NEV8 | |
| PPTPEDLMLSQYVYR | 1926 | Q8NG31 | |
| TLPDDYLSMDTLYPG | 221 | Q96QE4 | |
| YLSMDTLYPGSLPPE | 226 | Q96QE4 | |
| YTERYMGLPTPEDNL | 666 | P27487 | |
| AYAPEGSPILMPAYT | 51 | Q6P587 | |
| YRPMYSSDVPLDPLE | 701 | P14923 | |
| IPPSYRPTPDYETVM | 441 | Q16825 | |
| PSDRYHLMPIITPAY | 306 | P51003 | |
| RMGTPDPEYPDDYSQ | 231 | P05187 | |
| SDRYHLMPIITPAYP | 306 | Q9BWT3 | |
| PYSTELIFYIEMDPP | 21 | Q92569 | |
| QPYSLPTYDLGVMLP | 186 | O95677 | |
| EFPEYSRDPTMYLAL | 296 | Q8NB78 | |
| TTLRPTLMPYPELYN | 131 | Q8IY82 | |
| PVSPYMYISPPEALE | 186 | P05106 | |
| DKLPYPYDDPFSLMT | 121 | P18283 | |
| IEMLPGYRDPYSSRP | 391 | Q8IYK4 | |
| PMGNAEEPEIPYSYS | 76 | Q9UKT9 | |
| ASSDYMLRPPQPAVY | 666 | O95487 | |
| TPEPSYLDMDSYPEA | 156 | Q9BQG1 | |
| YDFLPETEPPEMLRN | 51 | Q14242 | |
| NMPSPSVDPYDTYEP | 561 | Q13033 | |
| PMPTAPRQDYIFYLE | 176 | Q13275 | |
| PEIEDMYSSPYLRPS | 511 | Q9Y4C2 | |
| ELSMALGTYYPPPRL | 286 | Q9HCE1 | |
| PSLDYSMPAPYRRVE | 586 | Q8TE76 | |
| SMPAPYRRVEAPVAY | 591 | Q8TE76 | |
| VPSYRPTPDYETVMR | 436 | Q15678 | |
| VRVAMYAPPEPIIDY | 171 | Q8IUH8 | |
| RMTYPEGAPLSDLEY | 241 | Q9UNP4 | |
| DSPYTPPSDSQRMIY | 1226 | Q8IZU2 | |
| YHPLDPVAYRLEPMI | 821 | Q9Y6Y8 | |
| EPSYRAPMEKLFYLP | 561 | Q15047 | |
| KLYEEVRIPYSEPMP | 436 | Q8N3C0 | |
| VRIPYSEPMPLSFEE | 441 | Q8N3C0 | |
| LYSLLEDPYPMVRST | 381 | Q86XI2 | |
| YDPPDPRRIYTIMSA | 11 | Q96LI5 | |
| LYEMVTLGAPPYPEV | 316 | Q6J9G0 | |
| PPLPAYDFLSMIDAA | 741 | Q9P2K2 | |
| GYPFLMIPDLSSPYL | 121 | Q9HCS4 | |
| PDIEMRAYPIEQYPC | 81 | Q96N76 | |
| SSYEPELFPGLIYRM | 281 | P20226 | |
| PEMVSVPLEDLDPYY | 71 | Q99250 | |
| LPPSYLDERYLSMPK | 1051 | Q8IZM8 | |
| LLYEMTYGRPPDSVP | 341 | Q7Z7A4 | |
| PDLSMDPYDGYDPSV | 521 | Q9NRL3 | |
| RYDFVLEYPRPVMPN | 256 | P19224 | |
| ASVPPMTYDPYDREL | 331 | Q69YN4 | |
| LGHDPYRLTPDPYRM | 951 | P18583 | |
| PRSPLFSPVVPYDMY | 56 | Q6SJ96 | |
| PYETSPSLLDYLTMD | 171 | Q8NBV4 | |
| RKPDIPVPYLYFDMG | 46 | Q96IK0 | |
| EREICMYSSLGYPPP | 76 | Q9H7M6 |